Nll Nebraska Lablinc competitors

Mr. Grossman has been a director of ADMA since 2007, has served as ADMA's President and Chief Executive Officer since October 2011 and as ADMA's President and Chief Operating Officer between 2007 and October 2011. Mr. Grossman has over 15 years of experience in the blood and plasma industry. Prior to founding ADMA, Mr. Grossman was the Executive Vice President of National Hospital Specialties and GenesisBPS, a position he held between 1994 and 2011. He has experience in launching new products, building and managing national and international sales forces, managing clinical trials, and completing numerous business development transactions. Previously, he worked at MedImmune, Inc., where he worked on marketing teams for RSV and CMV immunoglobulins, and at the American Red Cross, where he launched new products with the Biomedical Services division. Mr. Grossman received a B.S. in Business Administration, with a specialization in International Business and Marketing, from American University. Mr. Grossman is the son of Dr. Jerrold B. Grossman, ADMA’s Vice-Chairman.

Mark S Ordan is a Chief Executive Officer at MEDNAX INC, Board Member at Chamber Of Commerce Of The United States Of America, and Board Member at Fidelity & Trust Bank. He has experience at Goldman Sachs and has worked as Board Member at WASHINGTON PRIME GROUP INC., President/CEO at MILLS CORP, and Trustee at Federal Realty Invsmt Trust. Mark works or has worked as BOARD MEMBER at International Center for Research on Women, BOARD MEMBER at The Economic Club of Washington DC, and BOARD MEMBER at Seed Capital. He studied at Vassar College and Harvard Business School.

Bill Mosteller E. is a Chief Executive Officer at Diagnostic Laboratory of Oklahoma and is based in United States.

Tim Unger is a CEO:Parallon Technology at Parallon and President at Vision Consulting.

Alan Greenberg is a Chief Executive Officer and President at Sunrise Medical Laboratories and is based in Plainview, New York. He has worked as Chief Financial Officer at Sunrise Medical Laboratories and Sonic Healthcare USA-Northeast and Controller at QUEST DIAGNOSTICS INC.

Jake Orville has 20+ years of diagnostic, life science and medical device management experience within both established and emerging markets. As the General Manager of Pipeline at Exact Sciences, Jake leads the company's efforts to develop and advance solutions for earlier detection and life changing answers across the cancer continuum. Prior to Exact Sciences, Jake co-founded Cleveland HeartLab, Inc. (CHL) and served as the CEO from inception to exit. CHL was spun-out of the Cleveland Clinic to develop and rapidly commercialize unique diagnostic technologies, with applications in cardiovascular and inflammatory indications. CHL was acquired by Quest Diagnostics in December 2017. Jake Served as the General Manager of the Cardiometabolic & Endocrinology Franchise at Quest. Under Jake’s leadership, CHL was recognized as Ohio’s Venture of the Year (2012); received an Economic Impact Award by the city of Cleveland for job creation (2013) and was recognized as an Inc. 500 fastest growing private company in the US (2014). Jake has been recognized as a Top 50 Smart Leader by Smart Magazine and received the Annual Innovation Award in 2018 Prior to co-founding Cleveland HeartLab, Jake was CEO of Prognostix and held Senior Management positions with two publically traded companies (NextGen Sciences - AIM NGG.L; Third Wave Technologies - Nasdaq TWTI). He is a co-founder of Viridian Medical and Tolera Therapeutics and currently sits on the Board of Directors for The Wisconsin Women’s Health Foundation. Jake has raised capital from multiple sources, including top tier venture funds, strategic and international investors as well as angels, family offices and state funding sources. A well recognized entrepreneur, he has given many lectures on innovation, commercialization, early stage ventures, technology transfer and intellectual property. Jake received his Bachelor of Arts from the University of Massachusetts, Amherst and his MBA from the University of Wisconsin, Madison.